11:00 – 12:00 – PLENARY – Professor Jason Lewis (Memorial Sloan Kettering Cancer Center) “Radiopharmaceutical Chemistry – Precision Medicine in Cancer Treatment”

12:00 – 1:00 – Lunch

1:00 – 2:00 – Session 1

Prof Rachel Codd “Machining Chelators to Expand Targeted Radiopharmaceuticals”
Dr Benedict Lum “Repurposing antibody-drug conjugates into radiopharmaceuticals for the treatment of bladder cancer”
Dr Melyssa Grieve “Designing new chelators for targeted alpha therapy”

2:00 – 2:30 – Panel session (Prof Jason Lewis, MSKCC; Dr Ben Hughes, Therapeutic Innovation Australia; Prof Ros Francis, RBWH; Dr Ellen van Dam, Clarity Pharmaceuticals) Moderator: Dr James Wood

2:30 – 3:00 – Afternoon Tea

3:00 – 4:00 – Session 2

Dr Nick Fletcher “Pretargeting of PEG-based radiopharmaceutical nanomedicines – balancing stealth vs targeting”
Dr Pie Huda “Small antibody formats in radiopharmaceuticals; discovery and engineering”
Dr James Humphries “Real-Time Imaging of Protein Expression and the Host Immune Response Following mRNA Vaccination”

4:30 – 5:30 – Networking (Level 5 Centre for Advanced Imaging)

RSVP below.